CINGT (Cochlear Implant Neurotrophin Gene Therapy) Clinical Trial: A first-in-human study of a new UNSW-developed medical technology for directed gene delivery (BaDGE® – Bionic array Directed Gene Electrotransfer), engineered by Cochlear Ltd into a new medical device (a ‘Gene Delivery Array’ for creating an ‘electric
Using a decision tree approach to determine hearing aid ownership in older adults
A new study from MU Hearing’s Dr Yvonne Tran, Dr Diana Tang, Prof Bamini Gopinath, Prof Catherine McMahon, with Prof Paul Mitchell from The Westmead Institute aimed to understand the hearing loss characteristics that contribute to the decision of hearing aid ownership. The study concludes
How William and Michael found love from across the ‘sound divide’
William, a NextSense client who is deaf, and his partner Michael, who is hearing, recently shared how they embrace their differences to build a loving, healthy relationship that navigates both hearing and Deaf worlds.
CLaS Eye-tracking Workshop 1: Eye-tracking methods and paradigms
On 17th May 2022, Macquarie University’s Centre for Language Sciences (CLaS) hosted a half-day hybrid workshop on eye-tracking, an increasingly popular experimental method for speech and language research. The workshop was aimed at beginners to eye-tracking and focused on methodological approaches and commonly-used paradigms. With over
Trending Soundbites you may have missed in the last quarter
To Fit or Not to Fit Over 100 attendees around the world joined Dr Brent Edwards in a highly robust live discussion around ‘To fit or not to fit! Strategies for fitting no-to-mild hearing losses’. Should we recommend hearing devices to people with no-to-mild hearing
The National Acoustic Laboratories partners with WS Audiology to overcome barriers to better hearing
Through a new research collaboration, NAL will work closely with WS Audiology to investigate the knowledge and attitudes that Australians have about hearing solutions and factors that impact their decisions to use a hearing device.
Cochlear agrees to acquire Oticon Medical, Demant’s hearing implants business
Cochlear Limited, a global leader in implantable hearing solutions, agrees to acquire Oticon Medical for DKK850 million (approx. AUD170 million) following Demant’s decision to exit its hearing implants business activities. As part of the transaction, Cochlear has committed to providing ongoing support for Oticon Medical’s
NextSense welcomes Federal Budget funding injection for world-class centre for hearing and vision loss
NextSense welcomes the contribution of $12.5 million towards our new innovation centre at Macquarie University, which was announced in Tuesday’s Budget.
Macquarie University and NAL are delighted to welcome Dr Sriram Boothalingam
Macquarie University and National Acoustic Laboratories (NAL) are delighted to welcome Dr Sriram Boothalingam, from March 2022, in the first joint research appointment under the Macquarie University and NAL partnership program. Sriram will lead collaborative research to understand the listening brain and objective measures to
Australian Eye and Ear Health Survey
On World Hearing Day, Macquarie has hosted the launch of the Australian Eye and Ear Health Survey. This is the first time hearing has been included, with Inaugural Cochlear Chair in Hearing and Health at MU Hearing, Professor Bamini Gopinath, leading the ear health component.
NextSense CE welcomes Australian Eye and Ear Health survey
With the aim of raising awareness of hearing loss and what more can be done, NextSense Chief Executive Chris Rehn had an opinion piece published in the Newcastle Herald on World Hearing Day. The piece welcomes the launch of the Australian Eye and Ear Health